Firebrick Pharma Limited (AU:FRE) has released an update.
Firebrick Pharma Limited has launched its Nasodine Nasal Spray in Singapore, available for online purchase with consumer advertising approved by the Health Sciences Authority. Promoted as a germ-killing nasal spray, Nasodine is a ‘first-in-class’ product in the region, with potential future sales through pharmacies and partnerships. The product is priced at SGD 24.99 per bottle and is the first PVP-I nasal spray in Singapore, targeting increased consumer awareness post-COVID.
For further insights into AU:FRE stock, check out TipRanks’ Stock Analysis page.